DealForma
@dealforma
The deal and funding database built for biopharma. Curated deal comps, company profiles, pipelines, dedicated analyst support so you do better research faster
ID: 826231652930031616
http://dealforma.com 31-01-2017 00:52:31
279 Tweet
363 Followers
256 Following
In 2023-2024 YTD, the top M&A buyers by upfront cash and equity include Pfizer Inc. at $43.4 billion, BMS at $22.9 billion, @AbbVie at $18.9 billion, and J&J/Janssen at $17.6 billion. Want to see more charts like this? Schedule your demo hubs.ly/Q02JjqLd0
Our quarterly review of biopharma therapeutics and platforms dives deep into M&A deals.Vertex Pharmaceuticals acquired Alpine Immune Sciences in April 2024, enhancing its immunotherapy portfolio. Read the rest of our research on our blog. hubs.ly/Q02JQc4J0